This inventor holds 3 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: Glaxosmithkline Intellectual Property Development Limited. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2026
Title: David Dixon: Innovator in Medical Therapy
Introduction
David Dixon is a notable inventor based in Stevenage, GB. He has made significant contributions to the field of medical therapy, particularly through his work on interleukin 7 (IL-7) binding proteins. With a total of two patents to his name, Dixon's innovations are paving the way for advancements in treatment options for various diseases.
Latest Patents
Dixon's latest patents focus on IL-7 binding proteins and their applications in medical therapy. These patents provide detailed information on pharmaceutical compositions that utilize IL-7 binding proteins for the treatment or prevention of diseases and conditions. His work in this area highlights the potential of these proteins in enhancing therapeutic strategies.
Career Highlights
David Dixon is associated with GlaxoSmithKline Intellectual Property Development Limited, where he continues to develop innovative solutions in the medical field. His expertise and dedication to research have positioned him as a key figure in the advancement of medical therapies.
Collaborations
Dixon has collaborated with notable coworkers, including Gerben Bouma and Edward Thomas Coulstock. These partnerships have contributed to the successful development of his patents and the overall progress in their respective fields.
Conclusion
David Dixon's contributions to medical therapy through his patents on IL-7 binding proteins demonstrate his commitment to innovation and improvement in healthcare. His work continues to inspire advancements in treatment methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile